Results 181 to 190 of about 12,502 (244)

Role of vascular smooth muscle cell pathobiology in sepsis‑induced vasoplegia (Review). [PDF]

Int J Mol Med
Ruan H, Shen XY, Liu SY, Li SS.
europepmc   +1 more source

Effect of Levosimendan Use on All-Cause Mortality in Out-of-Hospital Cardiac Arrest Survivors After Extracorporeal Cardiopulmonary Resuscitation. [PDF]

Biomedicines
Chen DL, Lin YK, Wang GJ, Chang KC.
europepmc   +1 more source

Pre-Procedural Use of Levosimendan in High-Risk ACS-PCI Patients with Reduced Left Ventricle Ejection Fraction-Short-Term Outcomes. [PDF]

J Clin Med
Turkiewicz K, Kulczycki JJ, Rola P, Włodarczak S, Barycki M, Włodarczak P, Furtan Ł, Kozak P, Doroszko A, Banasiak W, Lesiak M, Włodarczak A.   +11 more
europepmc   +1 more source

Post-acute Myocardial Infarction Complication: A Ventricular Septal Defect. [PDF]

Cureus
Rodrigues Barbosa B, Cartucho J, Duarte T, Pona AP, Seixo F.   +4 more
europepmc   +1 more source

Non-mechanical haemodynamic support in acute pulmonary thromboembolism: a scoping review. [PDF]

Intensive Care Med Exp
Body W, Steckle S, Haggerty A, Putt M, Coyer F, Milford EM.   +5 more
europepmc   +1 more source

Levosimendan alleviates myocardial ischemia-reperfusion injury by regulating mitochondrial autophagy through cGAS-STING signaling pathway. [PDF]

J Clin Biochem Nutr
Shi F, Bao H, Meng F, Pang Y.
europepmc   +1 more source

Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis [PDF]

New England Journal of Medicine, 2016
BACKGROUND Levosimendan is a calcium-sensitizing drug with inotropic and other properties that may improve outcomes in patients with sepsis. METHODS We conducted a double-blind, randomized clinical trial to investigate whether levosimendan reduces the ...
Anthony C Gordon, Gavin D Perkins, Frcp, Fficm, Mervyn Singer   +2 more
exaly   +4 more sources